“…As lymphoedema is the second most feared side effect of cancer treatment among breast cancer patients (Cornelissen et al, 2018), it stands to reason that over-diagnosing lymphoedema will further increase existent distress (Alcorso & Sherman, 2015), therefore it is vital that an accurate diagnoses be made when measuring for lymphoedema. A larger cohort may present different outcomes, and with no papers (Lu et al, 2013;Öhberg et al, 2014;Lu et al, 2014;Erends et al, 2014;Buffa et al, 2015;Hoevenaren et al, 2016;Hameeteman et al, 2016;Cau et al, 2016;Levenhagen et al, 2017;Verhulst et al, 2017;Preuβ et al, 2018;Landau et al, 2018;Karakashian et al, 2018;Cau et al, 2018;Lu & Dixon, 2019;Karakashian et al, 2019;Binkley et al, 2020) reporting on 3DC's sensitivity or specificity against other methods, further research and analysis is needed.…”